ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,863Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 1001

$1.28M Total Retail Price of All Prescriptions

Rank: 12 out of 1001

860 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 860 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

4% of this provider’s 860 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 7,392 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

49% of this provider’s prescriptions were for brand-name drugs, compared to an average of 33%.

Prescription Price

$144 was the average price of a prescription from this provider, compared to $112 among peers.

Prescriptions per Patient

10 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
DONEPEZIL HCL 533 498 1 25
GABAPENTIN 410 337 2 17
NAMENDA 370 353 3 31
CARBIDOPA-LEVODOPA 308 286 4 60
PRIMIDONE 305 294 5 216
MIRTAZAPINE 305 278 5 68
LEVETIRACETAM 301 178 7 75
EXELON 284 263 8 87
PLAVIX 251 251 9 29
PENNSAID 220 191 10 10 292
SERTRALINE HCL 212 182 11 36
CYMBALTA 190 141 12 73
CLOPIDOGREL 187 173 13 28
LYRICA 177 118 14 117
AMANTADINE 145 145 15 324
VOLTAREN 144 121 16 115
GRALISE 124 99 10 17 280
OLANZAPINE 122 119 18 111
LIDODERM 104 101 19 108
PRAMIPEXOLE DIHYDROCHLORIDE 102 78 20 270
VIMPAT 99 51 21 238
CELEBREX 98 93 22 78
AZILECT 95 95 23 326
AGGRENOX 93 85 24 344
QUETIAPINE FUMARATE 93 92 24 76
DIVALPROEX SODIUM 89 40 26 90
ESCITALOPRAM OXALATE 84 80 27 110
SAVELLA 84 61 27 492
TRAMADOL HCL-ACETAMINOPHEN 82 67 29 171
NORTRIPTYLINE HCL 80 62 30 215
LEXAPRO 79 75 31 250
ZOLPIDEM TARTRATE 79 73 31 12
AMITRIPTYLINE HCL 73 45 R 33 255
SEROQUEL 71 65 34 191
ROPINIROLE HCL 69 67 35 274
CARBAMAZEPINE 69 31 35 220
ARICEPT 66 57 37 442
ZONISAMIDE 64 30 38 361
BACLOFEN 59 48 39 176
LAMOTRIGINE 56 0 40 121
LUNESTA 55 52 41 312
CARBIDOPA-LEVODOPA-ENTACAPONE 55 55 41 368
LOVAZA 55 55 41 39
NEUPRO 53 53 10 44 441
SUMATRIPTAN SUCCINATE 51 26 45 335
MIRAPEX ER 50 42 46 581
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 18, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.